Original Research
Published on 10 Aug 2023
Validation of the FACT-G7 in patients with hematologic malignancies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1183632
- 2,551 views
- 3 citations
Type at least 3 characters
2,053 articles
articles
Original Research
Published on 10 Aug 2023
Characterization of engraftment dynamics in myelofibrosis after allogeneic hematopoietic cell transplantation including novel conditioning schemes
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1205387
- 4,109 views
- 4 citations
Brief Research Report
Published on 03 Aug 2023
SARS-CoV-2 infection in high-risk children following tixagevimab–cilgavimab (Evusheld) pre-exposure prophylaxis: a single-center observational study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1229655
- 3,039 views
- 3 citations
Opinion
Published on 03 Aug 2023
A smoking gun? Clonal expansion in response to cigarette exposure
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1252643
- 1,876 views
- 1 citation
Mini Review
Published on 03 Aug 2023
Therapeutic targeting of leukemia stem cells in acute myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1204895
- 8,228 views
- 14 citations
Brief Research Report
Published on 03 Aug 2023
“Waitlist mortality” is high for myeloma patients with limited access to BCMA therapy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1206715
- 4,726 views
- 11 citations
Original Research
Published on 03 Aug 2023
Machine learning models-based on integration of next-generation sequencing testing and tumor cell sizes improve subtype classification of mature B-cell neoplasms
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1160383
- 4,085 views
- 1 citation
Review
Published on 03 Aug 2023
Management of chronic myelogenous leukemia with COVID-19 and hepatitis B
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1217023
- 3,050 views
- 2 citations
Original Research
Published on 03 Aug 2023
Monoclonal antibodies binding to different epitopes of CD20 differentially sensitize DLBCL to different classes of chemotherapy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1159484
- 4,345 views
- 1 citation
Editorial
Published on 01 Aug 2023
Editorial: New emerging functions of transcription factors and RNA-binding proteins in the development of hematological malignancies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1256461
- 1,631 views
Editorial
Published on 01 Aug 2023
Editorial: 50 years of BMT: long-term outcomes and late complications after transplantation
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1253971
- 1,766 views
- 2 citations
Editorial
Published on 31 Jul 2023
Editorial: Risk factors in multiple myeloma identified before and during treatment: are we ready to personalize treatment?
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1247808
- 2,307 views
- 2 citations
Editorial
Published on 25 Jul 2023
Editorial: Precision medicine for acute myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1233757
- 2,483 views
Original Research
Published on 24 Jul 2023
Impact of interval progression before autologous stem cell transplant in patients with multiple myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1216461
- 4,391 views
- 1 citation
Original Research
Published on 21 Jul 2023
Clinical and genetic characteristics in lymphoma patients with a second solid malignancy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1152290
- 3,293 views
- 2 citations
Original Research
Published on 21 Jul 2023
Calcineurin-independent NFATc1 signaling is essential for survival of Burkitt lymphoma cells
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1205788
- 4,719 views
- 1 citation
Original Research
Published on 21 Jul 2023
Cigarette smoke stimulates clonal expansion of Jak2V617F and Tet2-/- cells
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1210528
- 5,857 views
- 13 citations
Original Research
Published on 20 Jul 2023
Selection of hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1193237
- 4,317 views
- 11 citations
Systematic Review
Published on 20 Jul 2023
Induction treatment in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: a systematic review and meta-analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1188478
- 5,647 views
- 11 citations
Original Research
Published on 18 Jul 2023
The evolution of minimal residual disease: key insights based on a bibliometric visualization analysis from 2002 to 2022
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1186198
- 6,714 views
- 4 citations
Original Research
Published on 18 Jul 2023
Incidence, mortality, and survival of hematological malignancies in Northern Italian patients: an update to 2020
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1182971
- 4,165 views
- 5 citations
Review
Published on 17 Jul 2023
Extranodal NK-/T-cell lymphoma, nasal type: what advances have been made in the last decade?
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1175545
- 9,839 views
- 14 citations
Brief Research Report
Published on 17 Jul 2023
BCLXL PROTAC degrader DT2216 targets secondary plasma cell leukemia addicted to BCLXL for survival
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1196005
- 7,062 views
- 5 citations
Editorial
Published on 13 Jul 2023
Editorial: HBV and lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1236816
- 5,503 views
- 2 citations